Christopher Staten
Directeur/Membre du Conseil chez Aerie Pharmaceuticals Ireland Ltd.
Profil
Christopher Staten is currently a Director at Aerie Pharmaceuticals Ireland Ltd.
He was previously the Chief Financial Officer & Vice President at Aerie Pharmaceuticals, Inc. from 2015 to 2021.
He holds an MBA from Pace University and an undergraduate degree from Siena College.
Postes actifs de Christopher Staten
| Sociétés | Poste | Début |
|---|---|---|
Aerie Pharmaceuticals Ireland Ltd.
 Aerie Pharmaceuticals Ireland Ltd. Financial ConglomeratesFinance Part of Alcon AG, Aerie Pharmaceuticals Ireland Ltd. functions as an investment holding Irish company. The company is based in Athlone, Ireland. | Directeur/Membre du Conseil | 08/11/2018 |
Anciens postes connus de Christopher Staten
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 29/10/2021 |
Formation de Christopher Staten
| Pace University | Masters Business Admin |
| Siena College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Aerie Pharmaceuticals Ireland Ltd.
Aerie Pharmaceuticals Ireland Ltd. Financial ConglomeratesFinance Part of Alcon AG, Aerie Pharmaceuticals Ireland Ltd. functions as an investment holding Irish company. The company is based in Athlone, Ireland. | Finance |
